Cytokinetics, Inc. (CYTK)
61.62
-1.17
(-1.86%)
USD |
NASDAQ |
Oct 13, 16:00
62.01
+0.39
(+0.63%)
After-Hours: 20:00
Cytokinetics EPS Diluted (TTM) : -7.223 for June 30, 2026
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.223 |
| March 31, 2026 | -6.843 |
| December 31, 2025 | -6.534 |
| September 30, 2025 | -6.309 |
| June 30, 2025 | -5.122 |
| March 31, 2025 | -5.309 |
| December 31, 2024 | -5.278 |
| September 30, 2024 | -5.389 |
| June 30, 2024 | -5.372 |
| March 31, 2024 | -5.403 |
| December 31, 2023 | -5.452 |
| September 30, 2023 | -5.521 |
| June 30, 2023 | -5.692 |
| March 31, 2023 | -4.580 |
| December 31, 2022 | -4.252 |
| September 30, 2022 | -3.165 |
| June 30, 2022 | -2.594 |
| March 31, 2022 | -3.221 |
| December 31, 2021 | -2.830 |
| September 30, 2021 | -3.087 |
| June 30, 2021 | -2.186 |
| March 31, 2021 | -2.012 |
| December 31, 2020 | -2.016 |
| September 30, 2020 | -1.914 |
| June 30, 2020 | -2.372 |
| Date | Value |
|---|---|
| March 31, 2020 | -2.244 |
| December 31, 2019 | -2.115 |
| September 30, 2019 | -2.081 |
| June 30, 2019 | -1.980 |
| March 31, 2019 | -1.933 |
| December 31, 2018 | -1.957 |
| September 30, 2018 | -2.223 |
| June 30, 2018 | -2.420 |
| March 31, 2018 | -2.510 |
| December 31, 2017 | -2.57 |
| September 30, 2017 | -1.66 |
| June 30, 2017 | -0.29 |
| March 31, 2017 | 0.02 |
| December 31, 2016 | 0.33 |
| September 30, 2016 | -0.07 |
| June 30, 2016 | -1.07 |
| March 31, 2016 | -1.05 |
| December 31, 2015 | -0.97 |
| September 30, 2015 | -0.50 |
| June 30, 2015 | -0.43 |
| March 31, 2015 | -0.39 |
| December 31, 2014 | -0.43 |
| September 30, 2014 | -0.45 |
| June 30, 2014 | -0.72 |
| March 31, 2014 | -1.07 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Bristol Myers Squibb Co. | 4.539 |
| Alnylam Pharmaceuticals, Inc. | 5.923 |
| BioMarin Pharmaceutical, Inc. | 0.3709 |
| Exelixis, Inc. | 3.184 |
| Ionis Pharmaceuticals, Inc. | -3.473 |